{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:17:36Z","timestamp":1794961056776,"version":"4.9.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from von Hippel\u2013Lindau (VHL) disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A review of the literature was performed. Consensus was reached among authors regarding current practice, with reference to published data where possible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>von Hippel\u2013Lindau disease and its ocular manifestations are relatively rare, and there is limited evidence in the literature on which to base management. There was consensus on core principles, including 1) recognition and diagnosis of von Hippel\u2013Lindau disease when present, with appropriate referral for care of this potentially lethal systemic condition; 2) regular ophthalmic evaluation for individuals with von Hippel\u2013Lindau disease, to identify and offer timely treatment for new or active retinal hemangioblastomas; 3) ablative treatment of retinal hemangioblastomas that can be safely destroyed, to lower risk of vision loss; 4) observation or consideration of nonablative treatments for retinal hemangioblastomas that cannot be safely destroyed; and 5) observation of asymptomatic retinal vascular proliferation, with consideration of vitrectomy for lesions exerting effects on vision.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Ocular outcomes can be gratifying in many cases with appropriate management. Improved understanding of the molecular basis for the disease creates an opportunity for rational design of better therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002572","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T03:34:29Z","timestamp":1560569669000},"page":"2254-2263","source":"Crossref","is-referenced-by-count":78,"title":["MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL\u2013LINDAU DISEASE"],"prefix":"10.1097","volume":"39","author":[{"given":"Henry E.","family":"Wiley","sequence":"first","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Krivosic","sequence":"additional","affiliation":[{"name":"Service d'Opthalmologie, APHP, H\u00f4pital Lariboisi\u00e8re, Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9. France;"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Vasculaires Rares du Cerveau et de l'OEil (CERVCO), H\u00f4pital Lariboisi\u00e8re, APHP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gaudric","sequence":"additional","affiliation":[{"name":"Service d'Opthalmologie, APHP, H\u00f4pital Lariboisi\u00e8re, Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9. France;"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Vasculaires Rares du Cerveau et de l'OEil (CERVCO), H\u00f4pital Lariboisi\u00e8re, APHP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Gorin","sequence":"additional","affiliation":[{"name":"Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumour suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau's disease. Review of the literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"Am J Med"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000369362","article-title":"Management of von Hippel-Lindau Disease: An Interdisciplinary Review","volume":"37","author":"Schmid","year":"2014","journal-title":"Oncol Res Treat"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Genet"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/08820539209065107","article-title":"Von Hippel-Lindau disease: clinical considerations and the use of fluorescein-potentiated argon laser therapy for treatment of retinal angiomas","volume":"7","author":"Gorin","year":"1992","journal-title":"Semin Ophthalmol"},{"key":"R8-20230816","first-page":"1","article-title":"Clinically invisible retinal hemangioblastomas detected by spectral domain optical coherence tomography and fluorescein angiography in twins","volume":"0","author":"Schoen","year":"2016","journal-title":"Retin Cases Brief Rep"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0000000000001601","article-title":"Early detection of retinal hemangioblastomas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography","volume":"38","author":"Chen","year":"2018","journal-title":"Retina"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.1995.01100050083035","article-title":"Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients","volume":"113","author":"Shields","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/2013.jamaophthalmol.524","article-title":"Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases","volume":"131","author":"Shields","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R12-20230816","first-page":"232","article-title":"Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary?","volume":"119","author":"Singh","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","article-title":"Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oret.2016.08.004","article-title":"Laser photocoagulation for peripheral retinal capillary hemangioblastoma in von Hippel-Lindau disease","volume":"1","author":"Krivosic","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"R16-20230816","first-page":"446","article-title":"Fifteen year review of treated cases of retinal angiomatosis","volume":"83","author":"Annesley","year":"1977","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/eye.1989.5","article-title":"Laser treatment of retinal angiomatosis","volume":"3","author":"Lane","year":"1989","journal-title":"Eye"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0161-6420(90)32509-5","article-title":"Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser","volume":"97","author":"Blodi","year":"1990","journal-title":"Ophthalmology"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00006982-199616020-00011","article-title":"Clinicopathologic correlation of argon laser photocoagulation of retinal angiomas in a patient with von Hippel\u2013Lindau disease followed for more than 20 years","volume":"16","author":"Rosa","year":"1996","journal-title":"Retina"},{"key":"R20-20230816","first-page":"47","article-title":"Long-term results of laser treatment for retinal angiomatosis in von Hippel\u2013Lindau disease","volume":"5","author":"Schmidt","year":"2000","journal-title":"Eur J Med Res"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0161-6420(86)33637-6","article-title":"Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems","volume":"93","author":"Mainster","year":"1986","journal-title":"Ophthalmology"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1755-3768.2010.02008.x","article-title":"Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma","volume":"88","author":"Sachdeva","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.2012.259","article-title":"Photodynamic therapy for retinal capillary hemangioma","volume":"27","author":"Papastefanou","year":"2013","journal-title":"Eye"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0161-6420(98)98017-4","article-title":"Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma","volume":"105","author":"Kreusel","year":"1998","journal-title":"Ophthalmology"},{"key":"R25-20230816","first-page":"372","article-title":"Microsurgical resection of spinal cord hemangioblastomas","volume":"57","author":"Lonser","year":"2005","journal-title":"Neurosurgery"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archopht.125.9.1189","article-title":"Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma","volume":"125","author":"Schlesinger","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ophtha.2010.04.031","article-title":"Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel\u2013Lindau disease","volume":"118","author":"Gaudric","year":"2011","journal-title":"Ophthalmology"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000000707","article-title":"Pars plana vitrectomy in advanced cases of von Hippel-Lindau eye disease","volume":"36","author":"Krzystolik","year":"2016","journal-title":"Retina"},{"key":"R29-20230816","first-page":"48","article-title":"Therapeutic options for capillary papillary angiomas","volume":"107","author":"Garcia-Arum\u00ed","year":"2000","journal-title":"Ophthalmology"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0161-6420(02)01059-X","article-title":"Benefits and complications of photodynamic therapy of papillary capillary angiomas","volume":"109","author":"Schmidt-Erfurth","year":"2002","journal-title":"Ophthalmology"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajo.2014.05.003","article-title":"Long-term results after proton beam therapy for retinal papillary capillary hemangioma","volume":"158","author":"Seibel","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/IAE.0b013e318030a290","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel\u2013Lindau disease of the retina","volume":"27","author":"Dahr","year":"2007","journal-title":"Retina"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ophtha.2008.04.033","article-title":"Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel\u2013Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmol"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archopht.126.5.637","article-title":"Retinal vascular proliferation as an ocular manifestation of von Hippel\u2013Lindau disease","volume":"126","author":"Wong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.eye.6702896","article-title":"Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy","volume":"21","author":"Ziemssen","year":"2007","journal-title":"Eye"},{"key":"R36-20230816","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1752-1947-2-182","article-title":"Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: a case report","volume":"2","author":"de Klerk","year":"2008","journal-title":"J Med Case Rep"},{"key":"R37-20230816","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1111\/j.1755-3768.2009.01594.x","article-title":"Intravitreal bevacizumab for retinal capillary haemangioma: longterm results","volume":"88","author":"Ach","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R38-20230816","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1755-3768.2008.01449.x","article-title":"Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma","volume":"88","author":"Mennel","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R39-20230816","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcjo.2014.07.007","article-title":"Intravitreal bevacizumab for retinal capillary hemangioblastoma: a case series and literature review","volume":"49","author":"Slim","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"R40-20230816","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel\u2013Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:28:36Z","timestamp":1692232116000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002572","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}